References
- MannesseCKDerkxFHde RidderMAMan in ‘t VeldAJvan der CammenTJContribution of adverse drug reactions to hospital admission of older patientsAge Ageing2000291353910690693
- ZangerUMSchwabMCytochrome P450 enzymes in drug metabolism: regulation of gene expression, enzyme activities, and impact of genetic variationPharmacol Ther2013138110314123333322
- RuanoGSzarekBLVillagraDLength of psychiatric hospitalization is correlated with CYP2D6 functional status in inpatients with major depressive disorderBiomark Med20137342943923734807
- KroppSLichtinghagenRWintersteinKSchlimmeJSchneiderUCytochrome P-450 2D6 and 2C19 polymorphisms and length of hospitalization in psychiatryClin Lab2006525–623724016812949
- YepTDevineBA cost utility analysis of CYP2D6 pharmacogenetic guided dosing versus standard dosing of risperidone for treatment of schizophreniaValue Health2014173A217
- KellyLERiederMvan den AnkerJMore codeine fatalities after tonsillectomy in North American childrenPediatrics20121295e1343e134722492761
- RiederMJCarletonBPharmacogenomics and adverse drug reactions in childrenFront Genet201457824795743
- SamerCFLorenziniKIRollasonVDaaliYDesmeulesJAApplications of CYP450 testing in the clinical settingMol Diagn Ther201317316518423588782
- GoetzMPKnoxSKSumanVJThe impact of cytochrome P450 2D6 metabolism in women receiving adjuvant tamoxifenBreast Cancer Res Treat2007101111312117115111
- OlsonJERyuEJohnsonKJThe Mayo Clinic Biobank: a building block for individualized medicineMayo Clin Proc201388995296224001487
- BielinskiSJOlsonJEPathakJPreemptive genotyping for personalized medicine: design of the right drug, right dose, right time-using genomic data to individualize treatment protocolMayo Clin Proc2014891253324388019
- HaasLRTakahashiPYShahNDRisk-stratification methods for identifying patients for care coordinationAm J Manag Care201319972573224304255
- WeinerJPStarfieldBHSteinwachsDMMumfordLMDevelopment and application of a population-oriented measure of ambulatory care case-mixMed Care19912954524721902278
- BlackJL3rdWalkerDLO’KaneDJHarmandayanMFrequency of undetected CYP2D6 hybrid genes in clinical samples: impact on phenotype predictionDrug Metab Dispos201240111111922004686
- KramerWEWalkerDLO’KaneDJCYP2D6: novel genomic structures and allelesPharmacogenet Genomics2009191081382219741566
- JiYSkierkaJMBlommelJHPreemptive pharmacogenomic testing for precision medicine: a comprehensive analysis of five actionable pharmacogenomic genes using next-generation DNA sequencing and a customized CYP2D6 genotyping cascadeJ Mol Diagn201618343844526947514
- CraneSJTungEEHansonGJChaSChaudhryRTakahashiPYUse of an electronic administrative database to identify older community dwelling adults at high-risk for hospitalization or emergency department visits: the elders risk assessment indexBMC Health Serv Res20101033821144042
- NaessensJMStroebelRJFinnieDMEffect of multiple chronic conditions among working-age adultsAm J Manag Care201117211812221473661
- KhalighiBWuYFanWQCYP2D6 genetic information-guided metoprolol use in a cardiology clinic: a perspective studyCardiology2014128Suppl 1159
- Penas-LledoEMLlerenaACYP2D6 genetic polymorphism and psychiatry patients’ hospitalization periodBiomark Med20137691591624266825
- ShordSSCavallariLHGaoWThe pharmacokinetics of codeine and its metabolites in blacks with sickle cell diseaseEur J Clin Pharmacol200965765165819357842
- HamelinBATurgeonJValleeFBelangerPMPaquetFLeBelMThe disposition of fluoxetine but not sertraline is altered in poor metabolizers of debrisoquinClin Pharmacol Ther19966055125218941024
- Penas-LledoEGuillaumeSNaranjoMEA combined high CYP2D6-CYP2C19 metabolic capacity is associated with the severity of suicide attempt as measured by objective circumstancesPharmacogenomics J201515217217625113522
- KirchheinerJBrosenKDahlMLCYP2D6 and CYP2C19 genotype-based dose recommendations for antidepressants: a first step towards subpopulation-specific dosagesActa Psychiatr Scand2001104317319211531654
- TerraSGPaulyDFLeeCRBeta-adrenergic receptor polymorphisms and responses during titration of metoprolol controlled release/extended release in heart failureClin Pharmacol Ther200577312713715735607
- St SauverJLGrossardtBRLeibsonCLYawnBPMeltonLJ3rdRoccaWAGeneralizability of epidemiological findings and public health decisions: an illustration from the Rochester Epidemiology ProjectMayo Clin Proc201287215116022305027
- HeimMHMeyerUAEvolution of a highly polymorphic human cytochrome P450 gene cluster: CYP2D6Genomics199214149581358797